2006
ADAPT Research Group. Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT). PloS Clinical Trials, 1(7):e33, 2006. [PDF]
Akomolafe A, Lunetta KL, Erlich PM, Cupples LA, Baldwin CT, Huyck M, Green RC, Farrer LA. (2006) Genetic association between endothelial Nitric Oxide Synthase (NOS3) and Alzheimer disease. Clinical Genetics, 70:49-56. [PDF]
Akomolafe A, Beiser A, Meigs JB, Au R, Green RC, Farrer LA, Wolf PA, Seshadri S. (2006) Diabetes mellitus and risk of developing Alzheimer disease. Archives of Neurology 63:1551-1555. [PDF]
Binetti G, Benussi L, Roberts S, Villa A, Pasqualetti P, Sheu C-F, Gigola L, Lussignoli G, Dal Forno G, Barbiero L, Corbellini, Green RC, Rossini PM, Ghidoni R. (2006) Areas of intervention for genetic counselling of dementia: Cross-cultural comparison between Italians and Americans. Patient Education & Counseling [PDF]
Eckert SL, Katzen H, Roberts JS, Barber M, Ravdin LD, Relkin NR, Whitehouse PJ, Green RC. (2006) Recall of disclosed Apolipoprotein E genotype and lifetime risk estimate for Alzheimer’s disease: The REVEAL Study. Genetics in Medicine 8:746-751. [PDF]
Erlich PM, Lunetta KL, Cupples LA, Huyuck M, Green RC, Baldwin CT, Farrer LA. Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Human Molecular Genetics, 15:77-85, 2006. [PDF]
Erlich PM, Lunetta KL, Cupples LA, Huyck M, Green RC, Baldwin CT, Farrer LA. (2006) Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Human Molecular Genetics, 15:77-85. [PDF]
Gooding HC, Linnenbringer E, Burack J, Roberts JS, Green RC, Biesecker BB. (2006) Desire for genetic susceptibility testing for Alzheimer disease: Perceived threat and the need for information and control in the REVEAL Study. Patient Education & Counseling 64:259-267 [PDF]
Green RC, McNagny SE, Jayakumar P, Cupples LA, Benke K, Farrer LA: Statin use and the risk of Alzheimer’s disease. Alzheimer's & Dementia, 2006; 2:96-103.
Green RC, Dekosky ST: Primary prevention trials in Alzheimer’s disease. Neurology 67:S2-5, 2006. [PDF]
Green RC, McNagny SE, Jayakumar P, Cupples LA, Benke K, Farrer LA: Statin use and the risk of Alzheimer’s disease. Alzheimer’s & Dementia, 2:96-103, 2006. [PDF]
Jefferson AL, Barakat LP, Giovannetti T, Paul RH, Glosser G. Object perception impairments predict instrumental activities of daily living in Alzheimer's disease. Journal of Clinical & Experimental Neuropsychology, 2006; 28(6): 884-897. [PDF]
Jefferson AL, Cahn-Weiner D, Boyle PA, Paul RH, Gordon N, Moser D, Cohen RA. Cognitive predictors of changes in activities of daily living among patients with vascular dementia. International Journal of Geriatric Psychiatry, 2006; 21(8): 752-754. [PDF]
Jefferson AL, Glosser G, Detre JA, Sinson G, Liebeskind DS. Neuropsychological and perfusion MRI correlates of revascularization in a case of moyamoya syndrome. American Journal of Neuroradiology, 2006; 27(1):98-100. [PDF]
Jefferson AL, Paul RH, Ozonoff A, Cohen RA. Evaluating elements of executive functioning as predictors of instrumental activities of daily living (IADLs). Archives of Clinical Neuropsychology, 2006; 21(4): 311-320. [PDF]
Jefferson AL, Poppas A, Paul RH, Cohen RA. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiology of Aging, 2006. [PDF]
Jefferson AL, Wong S, Bolen E, Ozonoff A, Green RC, Stern RA. Cognitive predictors of HVOT performance differ between individuals with mild cognitive impairment and normal controls. Archives of Clinical Neuropsychology, 2006; 21:405-412. [PDF]
Nair A, Green RC: Alzheimer’s disease at 100 years. Practical Neurology, in press. [PDF]
Read C, Green RC, Smyer R (eds): Genetic Technology and the Future, Johns Hopkins Press, Baltimore, MD, in press.
Tsai DH, Green RC, Benke KS, Silliman RA, Farrer LA (2006) Predictors of subjective memory complaint in cognitively normal relatives of patients with Alzheimer’s disease. Journal of Neuropsychiatry and Clinical Neuroscience, 18:384-388. [PDF]
Tschanz JT, Welsh-Bohmer KA, Lyketsos CG, Corcoran C, Green RC…. Breitner JCS: Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology, 2006; 67:229-234. [PDF]
Wolozin B, Manger J, Bryant R, Cordy J, Green RC, McKee A. Cholesterol, Alzheimer’s disease and statins: Re-assessing the relationship between cholesterol, statins and Alzheimer’s disease. Acta Neuropathologica. 2006; 114:63-70. [Pubmed]
Yamin R, Bagchi S, Hildebrant R, Scaloni A, Widom RL, Abraham CR. Acyl Peptide Hydrolase, a Serine Proteinase Isolated from Conditioned Medium of Neuroblastoma Cells, Degrades the Amyloid ß Peptide. Journal of Neurochemistry. 2007; 100:458-467.
|
|
